The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, companies involved in the research, development, or production of pharmaceuticals, including veterinary drugs. It may invest in securities of foreign issuers. The fund is nondiversified. [profile from Yahoo]
The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in banking. These companies may include state chartered banks, banks that are members of the Federal Reserve System, and U.S. institutions whose deposits are not insured by the federal government. It may invest in securities of foreign issuers. [Profile from Yahoo.]
News 
Market Data 
Discover 
